デフォルト表紙
市場調査レポート
商品コード
1587338

コンパニオンアニマルヘルス市場:動物別、適応症別、タイプ別、最終用途別、流通チャネル別-2025~2030年世界予測

Companion Animal Health Market by Animal (Cats, Dogs, Horses), Indication (Behavioral Disorders, Dental Diseases, Dermatologic Diseases), Type, End-Use, Distribution Channel - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 192 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
コンパニオンアニマルヘルス市場:動物別、適応症別、タイプ別、最終用途別、流通チャネル別-2025~2030年世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンパニオンアニマルヘルス市場は、2023年に337億6,000万米ドルと評価され、2024年には397億2,000万米ドルに達すると予測され、CAGR 17.73%で成長し、2030年には1,059億2,000万米ドルに達すると予測されています。

コンパニオンアニマルヘルス市場は、予防、治療、診断ソリューションを通じて、猫、犬、鳥、小型哺乳類などのペットの幸福に焦点を当てたダイナミックなセクターです。このセグメントは、医薬品、ワクチン、栄養補助食品、診断検査、獣医療的サービスなど、ペットの長寿とQOL(生活の質)を向上させることを目的としています。こうした製品の必要性は、ペットの飼育率の上昇と、飼い主がより高い水準のケアを求めるペットの人間化によってもたらされています。治療範囲は予防医療から慢性・急性疾患の治療までと幅広く、包括的な動物ケアを保証します。最終用途セグメントは主に動物病院、動物病院、家庭などです。この市場の成長は、遠隔医療、ペットのためのウェアラブル技術、コンパニオンアニマルの警戒監視と健康管理を必要とする人獣共通感染症の有病率の上昇のような技術の進歩によって促進されます。注目すべきビジネス機会は、ペットの高齢化、保険需要の増加、遺伝子検査の進歩から生じており、これらは市場参入と開拓の機が熟しているセグメントです。企業は、ペットのための先進的診断と個別化医療をサポートする技術とインフラに投資することで、これらの機会を活用することができます。しかし、厳しい規制環境、医療製品やサービスに関連する高コスト、地域によっては獣医療へのアクセスが限られているなどの課題も残っています。このような制限に対処するには、製品の手頃な価格とコンプライアンスを改善するための強力な研究開発イニシアチブが必要です。イノベーションは、予防と治療を目的とした多機能製品の開発や、疾病の監視と管理を強化するためのAIとデータ分析の統合に重点を置くことができます。市場競争は激しいが有望であり、世界のペット飼育動向の上昇によって拡大余地が広がっています。戦略的パートナーシップ、飼い主教育への注力、特定のペットの健康ニーズに対応する多様な製品ラインアップは、市場の可能性をつかみ、このセグメントの事業成長を促進する上で極めて重要です。

主要市場の統計
基準年[2023年] 337億6,000万米ドル
予測年[2024年] 397億2,000万米ドル
予測年[2030年] 1,059億2,000万米ドル
CAGR(%) 17.73%

市場力学:急速に進化するコンパニオンアニマルヘルス市場の主要市場洞察を公開

コンパニオンアニマルヘルス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 政府と動物愛護協会によるイニシアチブの増加
    • 動物医療セグメントにおける技術の進歩
    • ペットの健康とコンパニオンアニマルの寿命延長に対する消費者の認識の変化
    • 可処分所得の増加とペットの飼い主がペットの医療に費やす余裕の増加
    • オンラインショッピングと宅配の増加が製品販売を促進
  • 市場抑制要因
    • 安価な偽造医薬品の増加
    • インフラ、資金、標準化の欠如
  • 市場機会
    • 安価な偽造医薬品の増加
    • インフラ、資金、標準化の欠如
  • 市場課題
    • 多くの国々で飼料への抗生物質や抗菌剤の使用が禁止されている、
    • 発展途上国における動物実験と獣医療に関連する高コスト

ポーターのファイブフォース:コンパニオンアニマルヘルス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:コンパニオンアニマルヘルス市場における外部からの影響の把握

外部マクロ環境要因は、コンパニオンアニマルヘルス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:コンパニオンアニマルヘルス市場における競合情勢の把握

コンパニオンアニマルヘルス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス:コンパニオンアニマルヘルス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コンパニオンアニマルヘルス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨:コンパニオンアニマルヘルス市場における成功への道筋を描く

コンパニオンアニマルヘルス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 政府や動物福祉団体による取り組みの増加
      • 動物医療セグメントにおける技術の進歩
      • ペットの健康とペットの寿命の延長に対する消費者の認識を変える
      • 可処分所得が増加し、ペットの飼い主はペットの医療にもっとお金をかけられるようになった
      • オンラインショッピングと宅配の増加が製品の売上を牽引
    • 抑制要因
      • 安価な偽造医薬品の増加
      • インフラ、資金、標準化の欠如
    • 機会
      • 安価な偽造医薬品の増加
      • インフラ、資金、標準化の欠如
    • 課題
      • 多くの国で動物飼料への抗生物質や抗菌剤の使用が禁止されている
      • 新興諸国における動物実験と獣医療に関連する高コスト
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 コンパニオンアニマルヘルス市場:動物別

  • イントロダクション

第7章 コンパニオンアニマルヘルス市場:適応症別

  • イントロダクション
  • 行動障害
  • 歯科疾患
  • 皮膚疾患
  • 感染症
  • 整形外科疾患

第8章 コンパニオンアニマルヘルス市場:タイプ別

  • イントロダクション
  • 医薬品添加飼料
    • アミノ酸
    • ミネラル
    • ビタミン
  • 栄養飼料添加物
    • 酵素
    • 飼料用酸性化剤
    • ホルモン
    • 免疫調節剤
    • プレバイオティクスとプロバイオティクス
  • 医薬品
    • 抗炎症
    • 抗生物質
    • 外部寄生虫駆除剤
    • 内部寄生虫駆除剤
  • ワクチン

第9章 コンパニオンアニマルヘルス市場:最終用途別

  • イントロダクション
  • ポイントオブケア検査または院内検査
  • 動物病院・クリニック

第10章 コンパニオンアニマルヘルス市場:流通チャネル別

  • イントロダクション
  • eコマース
  • 病院薬局
  • 小売

第11章 南北アメリカのコンパニオンアニマルヘルス市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋のコンパニオンアニマルヘルス市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのコンパニオンアニマルヘルス市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Alcami Corporation
  • B. Braun Melsungen AG
  • Bayer AG
  • Bioiberica S.A.U.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale S.A.
  • Cozmix Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Elanco US, Inc.
  • Eli Lilly and Company
  • IDEXX Laboratories, Inc.
  • Medtronic PLC
  • Merck & Co., Inc.
  • Nutreco N.V.
  • Perrigo Company PLC
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. COMPANION ANIMAL HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. COMPANION ANIMAL HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. COMPANION ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. COMPANION ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPANION ANIMAL HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DENTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY FEED ACIDIFIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY IMMUNE MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY POINT-OF-CARE TESTING OR IN-HOUSE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMAL HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY MEDICINAL ADDITIVE FEED, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY NUTRITIONAL FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN COM
目次
Product Code: MRR-4330CC794B35

The Companion Animal Health Market was valued at USD 33.76 billion in 2023, expected to reach USD 39.72 billion in 2024, and is projected to grow at a CAGR of 17.73%, to USD 105.92 billion by 2030.

The companion animal health market is a dynamic sector focusing on the well-being of pets like cats, dogs, birds, and small mammals through preventive, therapeutic, and diagnostic solutions. This sector's scope encompasses pharmaceuticals, vaccines, nutritional supplements, diagnostic tests, and veterinary services designed to enhance pet longevity and quality of life. The necessity for these offerings is driven by increasing pet adoption rates and the humanization of pets, where pet owners demand higher standards of care. Applications range from preventive healthcare measures to treatment of chronic and acute diseases, ensuring comprehensive animal care. End-use sectors primarily include veterinary clinics, animal hospitals, and households. Growth in this market is fueled by technological advancements like telemedicine, wearable technology for pets, and the rising prevalence of zoonotic diseases necessitating vigilant monitoring and health management of companion animals. Notable opportunities arise from the growing aging pet population, increasing demand for insurance, and advances in genetic testing, which are areas ripe for market entry and development. Companies can leverage these opportunities by investing in technology and infrastructure to support advanced diagnostics and personalized medicine for pets. However, challenges persist, including stringent regulatory environments, high costs associated with healthcare products and services, and limited access to veterinary care in certain regions. Addressing such limitations requires robust R&D initiatives to improve product affordability and compliance. Innovation can focus on developing multifunctional products that serve preventive and therapeutic purposes and integrating AI and data analytics for enhanced disease surveillance and management. The market is competitive but promising, with scope for expansion augmented by rising pet ownership trends worldwide. Strategic partnerships, focus on pet owner education, and diversified product lines that cater to specific pet health needs are crucial for seizing market potential and driving business growth in this sector.

KEY MARKET STATISTICS
Base Year [2023] USD 33.76 billion
Estimated Year [2024] USD 39.72 billion
Forecast Year [2030] USD 105.92 billion
CAGR (%) 17.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Health Market

The Companion Animal Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing initiatives by government and animal welfare associations
    • Technological advancements in the field of animal healthcare
    • Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
    • Increasing disposable incomes and pet owners afford to spend more on pet healthcare
    • Increasing online shopping and home delivery is driving the product sale
  • Market Restraints
    • Increase in cheap counterfeit drugs
    • Lack of infrastructure, funding, and standardization
  • Market Opportunities
    • Increase in cheap counterfeit drugs
    • Lack of infrastructure, funding, and standardization
  • Market Challenges
    • Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
    • High cost associated with animal testing and veterinary in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Health Market

A detailed market share analysis in the Companion Animal Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Companion Animal Health Market

A strategic analysis of the Companion Animal Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Health Market, highlighting leading vendors and their innovative profiles. These include Alcami Corporation, B. Braun Melsungen AG, Bayer AG, Bioiberica S.A.U., Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Cozmix Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Elanco US, Inc., Eli Lilly and Company, IDEXX Laboratories, Inc., Medtronic PLC, Merck & Co., Inc., Nutreco N.V., Perrigo Company PLC, Vetoquinol SA, Virbac SA, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Companion Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal, market is studied across Cats, Dogs, and Horses.
  • Based on Indication, market is studied across Behavioral Disorders, Dental Diseases, Dermatologic Diseases, Infectious Diseases, and Orthopedic Diseases.
  • Based on Type, market is studied across Medicinal Additive Feed, Nutritional Feed Additives, Pharmaceuticals, and Vaccines. The Medicinal Additive Feed is further studied across Amino Acids, Minerals, and Vitamins. The Nutritional Feed Additives is further studied across Enzymes, Feed Acidifiers, Hormones, Immune Modulators, and Prebiotics & Probiotics. The Pharmaceuticals is further studied across Anti-Inflammatory, Antibiotics, Ectoparasiticides, and Endoparasiticides.
  • Based on End-Use, market is studied across Point-of-care Testing or In-house Testing and Veterinary Hospitals & Clinics.
  • Based on Distribution Channel, market is studied across E-commerce, Hospital Pharmacies, and Retail.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing initiatives by government and animal welfare associations
      • 5.1.1.2. Technological advancements in the field of animal healthcare
      • 5.1.1.3. Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
      • 5.1.1.4. Increasing disposable incomes and pet owners afford to spend more on pet healthcare
      • 5.1.1.5. Increasing online shopping and home delivery is driving the product sale
    • 5.1.2. Restraints
      • 5.1.2.1. Increase in cheap counterfeit drugs
      • 5.1.2.2. Lack of infrastructure, funding, and standardization
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in cheap counterfeit drugs
      • 5.1.3.2. Lack of infrastructure, funding, and standardization
    • 5.1.4. Challenges
      • 5.1.4.1. Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
      • 5.1.4.2. High cost associated with animal testing and veterinary in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Companion Animal Health Market, by Animal

  • 6.1. Introduction
  • 6.2. Cats
  • 6.3. Dogs
  • 6.4. Horses

7. Companion Animal Health Market, by Indication

  • 7.1. Introduction
  • 7.2. Behavioral Disorders
  • 7.3. Dental Diseases
  • 7.4. Dermatologic Diseases
  • 7.5. Infectious Diseases
  • 7.6. Orthopedic Diseases

8. Companion Animal Health Market, by Type

  • 8.1. Introduction
  • 8.2. Medicinal Additive Feed
    • 8.2.1. Amino Acids
    • 8.2.2. Minerals
    • 8.2.3. Vitamins
  • 8.3. Nutritional Feed Additives
    • 8.3.1. Enzymes
    • 8.3.2. Feed Acidifiers
    • 8.3.3. Hormones
    • 8.3.4. Immune Modulators
    • 8.3.5. Prebiotics & Probiotics
  • 8.4. Pharmaceuticals
    • 8.4.1. Anti-Inflammatory
    • 8.4.2. Antibiotics
    • 8.4.3. Ectoparasiticides
    • 8.4.4. Endoparasiticides
  • 8.5. Vaccines

9. Companion Animal Health Market, by End-Use

  • 9.1. Introduction
  • 9.2. Point-of-care Testing or In-house Testing
  • 9.3. Veterinary Hospitals & Clinics

10. Companion Animal Health Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. E-commerce
  • 10.3. Hospital Pharmacies
  • 10.4. Retail

11. Americas Companion Animal Health Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Companion Animal Health Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Companion Animal Health Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcami Corporation
  • 2. B. Braun Melsungen AG
  • 3. Bayer AG
  • 4. Bioiberica S.A.U.
  • 5. Boehringer Ingelheim GmbH
  • 6. Ceva Sante Animale S.A.
  • 7. Cozmix Inc.
  • 8. Dechra Pharmaceuticals PLC
  • 9. Elanco Animal Health Incorporated
  • 10. Elanco US, Inc.
  • 11. Eli Lilly and Company
  • 12. IDEXX Laboratories, Inc.
  • 13. Medtronic PLC
  • 14. Merck & Co., Inc.
  • 15. Nutreco N.V.
  • 16. Perrigo Company PLC
  • 17. Vetoquinol SA
  • 18. Virbac SA
  • 19. Zoetis, Inc.